Hilton Capital Management, LLC Astrazeneca PLC Transaction History
Hilton Capital Management, LLC
- $1.22 Billion
- Q3 2024
A detailed history of Hilton Capital Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Hilton Capital Management, LLC holds 175,492 shares of AZN stock, worth $11.5 Million. This represents 1.12% of its overall portfolio holdings.
Number of Shares
175,492
Previous 171,571
2.29%
Holding current value
$11.5 Million
Previous $13.4 Million
2.2%
% of portfolio
1.12%
Previous 1.15%
Shares
10 transactions
Others Institutions Holding AZN
# of Institutions
1,361Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.12 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.75 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.44 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.41 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.25 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $203B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...